Price Transparency regulations are expanding fast, and so are the consequences for non-compliance. With over a dozen states now enforcing aggressive reporting requirements, even a single missed WAC increase notice or new product report can result in fines of $5,000, $10,000, or even $30,000 per day.
In this essential on-demand session, RLDatix Life Sciences VP of Knowledge Management Sarah McClure and Senior Analyst Kristin Rademacher provide a timely overview of:
- The latest regulatory updates and what they mean for your reporting calendar
- Key differences in state-specific triggers, thresholds, and timelines
- Why generic, branded, and biosimilar products all fall under scrutiny
- How to reduce your compliance burden with automated reporting and managed services
What You’ll Learn:
- Which states are most likely to fine, and how much
- How to model price increases to stay ahead of 60-day requirements
- Why spreadsheets aren’t enough for modern compliance
- How RLDatix Life Sciences supports your price transparency
Real penalties. Real complexity. Real risk. Be sure to watch the webinar to stay ahead on price transparency.
Thank You for Watching!
Civil monetary penalties are real, are rising, and are being enforced with surprising speed and severity. In fact, one manufacturer was recently hit with a $900,000 fine from a single state. Others are scrambling to meet complex reporting timelines, navigate outdated portals, and manage multiple price triggers across branded, generic, and biosimilar products.
If you have any questions, please contact us at info@rldatixlifesciences.com to connect with one of our seasoned experts.